GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,862.50p
   
  • Change Today:
    -10.00p
  • 52 Week High: 2,208.00
  • 52 Week Low: 1,344.00
  • Currency: UK Pounds
  • Shares Issued: 4,054.82m
  • Volume: 11,082,277
  • Market Cap: £75,521m
  • RiskGrade: 129
  • Beta: 0.00

Latest ShareCast News

GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme

By Iain Gilbert

Date: Monday 11 May 2026

(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pharmaceutical to accelerate its chronic hepatitis B treatment, bepirovirsen, in mainland China.

GSK ShareCast News

Sales jump at GSK on strong demand for specialty... 29-Apr-2026 ShareCast
GSK hepatitis B drug secures FDA priority review 28-Apr-2026 ShareCast
US court rules against GSK in dispute with Anapt... 27-Apr-2026 ShareCast
GSK's Blenrep gets green light from China's NMPA 20-Apr-2026 ShareCast
GSK ovarian, womb cancer drug posts positive res... 13-Apr-2026 ShareCast

GSK Regulatory News

Director/PDMR Shareholding 14-May-2026 15:30 RNS
Director/PDMR Shareholding 11-May-2026 15:30 RNS
Collaboration with CTTQ for bepirovirsen 11-May-2026 07:05 RNS
GSK - final tranche of share buyback programme 11-May-2026 07:00 RNS
Result of AGM 06-May-2026 18:22 RNS

GSK Newspaper Links

Strong vaccine sales deliver an early boost for ... 29-Apr-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,862.50p
Change Today -10.00p
% Change -0.53 %
52 Week High 2,208.00
52 Week Low 1,344.00
Volume 11,082,277
Shares Issued 4,054.82m
Market Cap £75,521m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-26 19-Feb-26
Paid 09-Jul-26 09-Apr-26
Amount 17.00p 18.00p

Trades for 15-May-2026

Time Volume / Share Price
16:09 1 @ 1,859.50p
15:55 0 @ 1,862.50p
15:55 0 @ 1,862.50p
15:55 0 @ 1,862.50p
15:55 0 @ 1,862.50p

GSK Key Personnel

CEO Luke Miels

Top of Page